Everolimus Tablet
Product Images NDC 63850-0107

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 63850-0107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Everolimus 0 25mg Bottle Label

Everolimus Tablets 0.25 mg oral tablets manufactured by Natco Pharma Limited. The label includes dosing instructions to see package insert, a warning to keep out of reach of children, and storage instructions at 25°C with permitted excursions. It indicates the package contains 60 tablets with a pharmacist dispensing instruction for each patient. Additional batch and expiration placeholders are visible but not legible.*

FDA Label Image

Carton (Everolimus 0 25mg Carton)

Packaging label for Everolimus Tablets, 0.25 mg per tablet, manufactured by Natco Pharma Limited, India. The label includes storage instructions to keep the medication at 25°C (77°F) with permitted excursions between 15°C-30°C (59°F-86°F) in the original aluminum blister. It also contains a warning to keep out of reach of children, a barcode, and advises dispensing with a medication guide enclosed. The label indicates the product is for prescription use only and comes in a carton containing 60 tablets in individual blister cards.*

FDA Label Image

Foil (Everolimus 0 25mg Foil)

Blister card label for Everolimus Tablet 0.25 mg by Natco Pharma Limited. The label includes multiple identical sections, each showing the product name, strength, manufacturer, barcode, and issue date of 04/2021. Each section also has spaces for batch number and expiration date to be filled in.*

FDA Label Image

Everolimus 0 5mg Bottle Label

Everolimus 0.5 mg oral tablets packaging label from Natco Pharma Limited. The label includes medication warnings, storage instructions, and pharmacist dispensing guidance. The label indicates the package contains 60 tablets with a prescription-only designation.*

FDA Label Image

Carton (Everolimus 0 5mg Carton)

Everolimus tablets packaging label showing 0.5 mg per tablet strength. The label includes storage instructions, a warning to keep out of reach of children, and manufacturer information stating Natco Pharma Limited, India. The package contains 60 tablets and features the NDC code 63850-0063-2 with a barcode.*

FDA Label Image

Foil (Everolimus 0 5mg Foil)

Blister pack label for Everolimus Tablet, 0.5 mg, manufactured by Natco Pharma Ltd. The label includes the NDC number 63850-0063-3, manufacturing date 04/2021, and a barcode. Multiple individual tablet compartments are shown, each with the same printed information and space for batch number and expiration date.*

FDA Label Image

Everolimus 0 75mg Bottle Label

Everolimus Tablets 0.75 mg oral tablets packaging label showing the product name, strength, and form. The label includes directions for pharmacists to dispense the accompanying medication guide. It states that the package contains 60 tablets and is manufactured by Natco Pharma Limited, located in India. Storage instructions and warnings about keeping the medication out of reach of children are also visible.*

FDA Label Image

Carton (Everolimus 0 75mg Carton)

The packaging label for Everolimus Tablets 0.75 mg per tablet, an oral dosage form manufactured by Natco Pharma Limited, India. The label includes storage instructions to keep the product at 25°C with permitted excursions, warnings to keep out of reach of children, and a barcode with NDC 63850-0064-2. The label indicates the product is prescription-only and contains 60 tablets in blister cards.*

FDA Label Image

Foil (Everolimus 0 75mg Foil)

A blister pack label for Everolimus Tablet, 0.75 mg, manufactured by Natco Pharma Limited. The label displays repeating segments each showing the NDC number 63850-0064-3, the dosage strength (0.75 mg), manufacturer details, issue date of 04/2021, and a barcode on each segment. The label includes spaces for batch number and expiration date.*

FDA Label Image

Everolimus-fig-1 (Everolimus Fig 1)

A line graph depicting estimated glomerular filtration rate (eGFR) over multiple visit windows from screening to 24 months. It compares two treatment groups: EVR+Reduced TAC and TAC Control, showing eGFR values on the y-axis and visit windows on the x-axis, with error bars for variability.*

FDA Label Image

Everolimus Chemical Structure (Everolimus Structure)

Chemical structure diagram of the active ingredient Everolimus, showing its molecular arrangement with labeled atoms and bonds as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.